The impact of price transparency on consumers and providers: A scoping review

Zhang, Angela; Prang, Khic-Houy; Devlin, Nancy; Scott, Anthony; Kelaher, Margaret

doi:10.1016/j.healthpol.2020.06.001

Cited by 48 publications

(61 citation statements)

References 32 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Perhaps they preferred more health care services within the delivery episode. Previous research has generally shown that price transparency tools are not associated with selection of lower-priced facilities 7 , 8 , 9 , 10 , 11 ; more studies are needed to trace whether this finding would continue to be true over time.…”

Section: Discussionmentioning

confidence: 95%

“… 3 , 4 , 5 , 6 Studies showed that use of these tools was associated with lower spending on imaging services but not on other services. 4 , 7 , 8 , 9 , 10 , 11 Nonetheless, price estimates for some medical services were queried more frequently than others. These so-called shoppable services tended to be routine, have higher out-of-pocket costs, and be nonemergent (eg, imaging services), allowing patients time to seek price information as they planned for care.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Patterns of Use of a Price Transparency Tool for Childbirth Among Pregnant Individuals With Commercial Insurance

et al. 2021

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 95%

Section: Introductionmentioning

confidence: 99%

Patterns of Use of a Price Transparency Tool for Childbirth Among Pregnant Individuals With Commercial Insurance

et al. 2021

View full text Add to dashboard Cite

show abstract

“…Insurance carriers could also make cost estimator tools available to patients online. These tools already exist for some insurance plans, but they have had very poor uptake, 40 , 42 , 43 , 44 perhaps in part because patients who use them still have to contact their clinicians to request alternative medications or procedures when costs are too high. Better yet, insurance companies could simplify their cost-sharing mechanisms, especially as evidence grows that patients are bad at choosing insurance plans that provide the most coverage for the least amount of money.…”

Section: Discussionmentioning

confidence: 99%

Accuracy of Physician Estimates of Out-of-Pocket Costs for Medication Filling

et al. 2021

View full text Add to dashboard Cite

IMPORTANCE One-third of US residents have trouble paying their medical bills. They often turn to their physicians for help navigating health costs and insurance coverage.OBJECTIVE To determine whether physicians can accurately estimate out-of-pocket expenses when they are given all of the necessary information about a drug's price and a patient's insurance plan. DESIGN, SETTING, AND PARTICIPANTSThis national mail-in survey used a random sample of US physicians. The survey was sent to 900 outpatient physicians (300 each of primary care, gastroenterology, and rheumatology). Physicians were excluded if they were in training, worked primarily for the Veterans Administration or Indian Health Service, were retired, or reported 0% outpatient clinical effort. Analyses were performed from July to December 2020. MAIN OUTCOMES AND MEASURESIn a hypothetical vignette, a patient was prescribed a new drug costing $1000/month without insurance. A summary of her private insurance information was provided, including the plan's deductible, coinsurance rates, copays, and out-of-pocket maximum.Physicians were asked to estimate the drug's out-of-pocket cost at 4 time points between January and December, using the plan's 4 types of cost-sharing: (1) deductibles, (2) coinsurance, (3) copays, and (4) out-of-pocket maximums. Multivariate linear regression was used to assess differences in performance by specialty, adjusting for attitudes toward cost conversations, demographics, and clinical characteristics. RESULTSThe response rate was 45% (405 of 900) and 371 respondents met inclusion criteria.Among the respondents included in this study, 59% (n = 220) identified as male, 23% (n = 84) as Asian, 3% (n = 12) as Black, 6% (n = 24) as Hispanic, and 58% (n = 216) as White; 30% (n = 112) were primary care physicians, 35% (n = 128) were gastroenterologists, and 35% (n = 131) were rheumatologists; and the mean (SD) age was 49 (10) years. Overall, 52% of physicians (n = 192) accurately estimated costs before the deductible was met, 62% (n = 228) accurately used coinsurance information, 61% (n = 224) accurately used copay information, and 57% (n = 210) accurately estimated costs once the out-of-pocket maximum was met. Only 21% (n = 78) of physicians answered all 4 questions correctly. Ability to estimate out-of-pocket costs was not associated with specialty, attitudes toward cost conversations, or clinic characteristics. CONCLUSIONS AND RELEVANCEThis survey study found that many US physicians have difficulty estimating out-of-pocket costs, even when they have access to their patients' insurance plans. The mechanics involved in calculating real-time out-of-pocket costs are complex. These findings suggest that increased price transparency and simpler insurance cost-sharing mechanisms are needed to enable informed cost conversations at the point of prescribing.

show abstract

“…También existen interacciones entre precio y garantía, se debe considerar ambos factores simultáneamente cuando se elabora la estrategia de marketing, que determine ganancias y supervivencia. Además, el precio y la garantía deben ser igualmente importantes cuando realizan e integran las estrategias (Zhang, et al, 2020;Díaz & Díaz, 2018). En definitiva, dada la gran influencia que el precio tiene sobre la demanda y las ganancias, las políticas de precios son decisiones comerciales fundamentales, por los múltiples productos en diferentes categorías (Karray, Martín-Herrán, & Zaccour, 2020).…”

Section: • Preciounclassified

Estrategia competitiva en el sector Construcción: Uso de fibras de Cáñamo

Hernández¹,

Martinez-Montaña²,

Junco³

2021

RVG

View full text Add to dashboard Cite

Las construcciones de tipo civil contribuyen al crecimiento económico de un país, razón por la cual la utilización de materiales de refuerzo como las fibras van en aumento en proyectos de construcción. De ahí que el objetivo de esta investigación fue evaluar las percepciones frente al uso de fibras naturales (cáñamo) y a las fibras sintéticas (vidrio), en empresas dedicadas a la construcción en el departamento de Boyacá, como un estrategia organizacional de competitividad. Se utilizó el método de escalamiento multidimensional no métrico y el procedimiento de escala de mínimos cuadrados alternos, donde los consumidores potenciales hicieron juicios de similitud, con 9 atributos ordenando las respuestas en tres grupos, que dieron como resultado 5 iteraciones para llegar a un Stress de 0,09688 indicando un buen ajuste. Se concluye que la asociación de los factores técnico, estratégico y psicológico; influyen en la decisión de compra, los parámetros ambientales no son considerados como relevantes; mientras el precio y durabilidad afectan el comportamiento del consumidor. Finalmente los aspectos legales en Colombia, determinan la viabilidad económica y técnica para este sector en la actualidad.

show abstract

The impact of price transparency on consumers and providers: A scoping review

Cited by 48 publications

References 32 publications

Patterns of Use of a Price Transparency Tool for Childbirth Among Pregnant Individuals With Commercial Insurance

Patterns of Use of a Price Transparency Tool for Childbirth Among Pregnant Individuals With Commercial Insurance

Accuracy of Physician Estimates of Out-of-Pocket Costs for Medication Filling

Estrategia competitiva en el sector Construcción: Uso de fibras de Cáñamo

Contact Info

Product

Resources

About